Quality analysis of BCG vaccine for bladder cancer immunotherapy using Shewhart control charts
https://doi.org/10.30895/2221-996X-2024-24-1-76-90
Abstract
SCIENTIFIC RELEVANCE. The complexity of standardising immunobiologicals, including bacillus Calmette–Guérin (BCG) vaccines, requires improving the approach to statistical analysis of consistency in their quality indicators. Quality analysis tools include Shewhart control charts, which can be used for real-time and retrospective identification and analysis of trends in the processes of interest.
AIM. This study aimed to analyse quality indicators of a BCG vaccine for bladder cancer immunotherapy using Shewhart control charts to monitor consistency in manufacturing processes and quality testing of vaccines.
MATERIALS AND METHODS. The study involved a retrospective analysis of the bacterial concentration, dispersity index, loss-on-drying, and potency data obtained during the quality control of Imuron-vac, a BCG vaccine for bladder cancer immunotherapy, in the past 5 years. As part of the statistical data analysis, the authors calculated the means, investigated the correlation between the test results provided by the manufacturer and the quality control results obtained at the testing centre (TC), and checked the distributions for normality. Individuals and moving range control charts were plotted and analysed for each quality indicator.
RESULTS. The correlation coefficients (r) ranged from 0.34 to 0.70 for the data submitted by the manufacturer and the data obtained at the TC. Pearson’s goodness-of-fit test showed that the distribution of the quality control results obtained at the TC was normal, with χ² = 14.03 for the dispersity index values and χ² = 4.93 for the loss-on-drying measurements. Shewhart control charts for loss-on-drying and potency data suggested that the production process and/or the testing process deviated from the state of statistical control. Consistency monitoring of the bacterial concentration and the dispersity index showed that the state of statistical control was achieved. The authors established control limits for further real-time monitoring of the dispersity index consistency.
CONCLUSIONS. Shewhart control charts are applicable to the quality control of BCG vaccines for bladder cancer immunotherapy at the TC. Continuous monitoring of consistency in quality indicators is needed to improve the standardisation of vaccine production processes and testing methods, as this standardisation will result in high product quality.
Keywords
About the Authors
A. A. SavinaRussian Federation
Anna A. Savina
8/2 Petrovsky Blvd, Moscow 127051
A. A. Voropaev
Russian Federation
Andrey A. Voropaev
8/2 Petrovsky Blvd, Moscow 127051
A. A. Alesina
Russian Federation
Anna A. Alesina
8/2 Petrovsky Blvd, Moscow 127051
References
1. Jeong SH, Han JH, Jeong CW, Kim HH, Kwak C, Yuk HD, Ku JH. Clinical determinants of recurrence in pTa bladder cancer following transurethral resection of bladder tumor. BMC Cancer. 2022;22(1):631. https://doi.org/10.1186/s12885-022-09733-8
2. Konyashkina SYu, Reva SA, Petrov SB. Laboratory predictors to intravesical BCG therapy response in patients with non-muscle invasive bladder cancer. Urology Herald. 2022;10(4):155–64 (In Russ.) https://doi.org/10.21886/2308-6424-2022-10-4-155-164
3. Herr HW, Morales A. History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story. J Urol. 2008;179(1):53–6. https://doi.org/10.1016/j.juro.2007.08.122
4. Jiang S, Redelman-Sidi G. BCG in bladder cancer immunotherapy. Cancers (Basel). 2022;14(13):3073. https://doi.org/10.3390/cancers14133073
5. Mukherjee N, Julián E, Torrelles JB, Svatek RS. Effects of Mycobacterium bovis Calmette et Guérin (BCG) in oncotherapy: bladder cancer and beyond. Vaccine. 2021;39(50):7332–40. https://doi.org/10.1016/j.vaccine.2021.09.053
6. Solonin SI. Control charts method. Moscow–Berlin: Direct-Media; 2015 (In Russ.). EDN: VQENBJ.
7. Shper VL. Quality tools and something more! Part 7. Shewhart control charts (continued). Methods of Quality Management. 2022;(2):48–54 (In Russ.). EDN: CSBWIH
8. Ilyuchenko IYu, Chernova AP. Water treatment monitoring systems. Shewhart control charts. Laboratory and Production. 2020;13(3–4):130–9 (In Russ.). https://doi.org/10.32757/2619-0923.2020.3-4.13.130.139
9. Zhu Fugen. Application of Shewhart control charts in the inspection of pharmaceutical manufacturing process. Int J Pharm Chem. 2019;5(1):1–11. https://doi.org/10.11648/j.ijpc.20190501.11
10. Suman G, Prajapati DR. Control chart applications in healthcare: a literature review. Int J Metrol Qual Eng. 2018;(9):5. https://doi.org/10.1051/ijmqe/2018003
11. Savina AA, Aleksandrova NV, Nemirovskaya TI. Using Shewhart charts to monitor quality characteristics of preventive vaccines for tuberculosis. Biological Products. Prevention, Diagnosis, Treatment. 2023;23(3):310–20 (In Russ.). https://doi.org/10.30895/2221-996X-2023-23-3-310-320
12. Fadeikina OV, Voropaev AA, Davydov DS, Volkova RA. Estimation of measurement uncertainty for the determination of loss on drying of biologicals. Biological Products. Prevention, Diagnosis, Treatment. 2023;23(3–1):452–62 (In Russ.). https://doi.org/10.30895/2221-996X-2023-23-3-1-452-462
13. Moghawry HM, Rashed ME, Gomaa K, AbdelGhani S, Dishisha T. Development of a fast and precise potency test for BCG vaccine viability using flow cytometry compared to MTT and colony-forming unit assays. Sci Rep. 2023;13(1):11606. https://doi.org/10.1038/s41598-023-38657-x
14. Yang YC, Tsai MH, Cheng HF. Determine the potency of BCG vaccines by flow cytometer. Biotechnol Biotechnol Equip. 2011;(25):2394–8. https://doi.org/10.5504/BBEQ.2011.0048
15. Singh Jadaun GP, Kasana H, Malik N. Quality control testing of BCG vaccine: current practices and technological advancements. Int J Vaccine Res. 2016;1(1):4. https://doi.org/10.15226/2473-2176/1/1/00103
16. Gweon E, Choi C, Kim J, Kim B, Kang H, Park T, et al. Development of a new approach to determine the potency of bacille Calmette–Guérin vaccines using flow cytometry. Osong Public Health Res Perspect. 2017;8(6):389–96. https://doi.org/10.24171/j.phrp.2017.8.6.06
17. Fedorova OV, Ponkratova SA, Valeeva RT, Islamgulov IR. Growth media in the production of medicinal products for human and veterinary use. Bulletin of Technological University. 2017;20(4):130–3 (In Russ.). EDN: XYEEVX
18. Larionova EE, Andrievskaya IYu, Andreevskaya SN, Smirnova TG, Sevastianova EV. Culture method for studying mycobacteria. Solid growth media. CTRI Bulletin. 2020;(3):75–86 (In Russ.).
Supplementary files
Review
For citations:
Savina A.A., Voropaev A.A., Alesina A.A. Quality analysis of BCG vaccine for bladder cancer immunotherapy using Shewhart control charts. Biological Products. Prevention, Diagnosis, Treatment. 2024;24(1):76-90. (In Russ.) https://doi.org/10.30895/2221-996X-2024-24-1-76-90